240 related articles for article (PubMed ID: 24676092)
21. Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels.
M'Barek S; Mosbah A; Sandoz G; Fajloun Z; Olamendi-Portugal T; Rochat H; Sampieri F; Guijarro JI; Mansuelle P; Delepierre M; De Waard M; Sabatier JM
Eur J Biochem; 2003 Sep; 270(17):3583-92. PubMed ID: 12919322
[TBL] [Abstract][Full Text] [Related]
22. Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin.
Meng L; Xie Z; Zhang Q; Li Y; Yang F; Chen Z; Li W; Cao Z; Wu Y
J Biol Chem; 2016 Mar; 291(13):7097-106. PubMed ID: 26817841
[TBL] [Abstract][Full Text] [Related]
23. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
[TBL] [Abstract][Full Text] [Related]
24. The investigation of interactions of kappa-Hefutoxin1 with the voltage-gated potassium channels: a computational simulation.
Zarrabi M; Naderi-Manesh H
Proteins; 2008 May; 71(3):1441-9. PubMed ID: 18076029
[TBL] [Abstract][Full Text] [Related]
25. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
[TBL] [Abstract][Full Text] [Related]
26. Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.
Bhuyan R; Seal A
Biophys Chem; 2015; 203-204():1-11. PubMed ID: 26001067
[TBL] [Abstract][Full Text] [Related]
27. N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.
Nekrasova OV; Primak AL; Ignatova AA; Novoseletsky VN; Geras'kina OV; Kudryashova KS; Yakimov SA; Kirpichnikov MP; Arseniev AS; Feofanov AV
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33339256
[TBL] [Abstract][Full Text] [Related]
28. An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility.
Bartok A; Fehér K; Bodor A; Rákosi K; Tóth GK; Kövér KE; Panyi G; Varga Z
Sci Rep; 2015 Dec; 5():18397. PubMed ID: 26689143
[TBL] [Abstract][Full Text] [Related]
29. Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family.
Chen ZY; Hu YT; Yang WS; He YW; Feng J; Wang B; Zhao RM; Ding JP; Cao ZJ; Li WX; Wu YL
J Biol Chem; 2012 Apr; 287(17):13813-21. PubMed ID: 22354971
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms Underlying the Inhibition of KV1.3 Channel by Scorpion Toxin ImKTX58.
Zhang X; Zhao Q; Yang F; Lan Z; Li Y; Xiao M; Yu H; Li Z; Zhou Y; Wu Y; Cao Z; Yin S
Mol Pharmacol; 2022 Sep; 102(3):150-160. PubMed ID: 35764383
[TBL] [Abstract][Full Text] [Related]
31. sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity.
Csoti A; Del Carmen Nájera Meza R; Bogár F; Tajti G; Szanto TG; Varga Z; Gurrola GB; Tóth GK; Possani LD; Panyi G
Biochem Pharmacol; 2022 May; 199():115023. PubMed ID: 35358481
[TBL] [Abstract][Full Text] [Related]
32. Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
Legros C; Schulze C; Garcia ML; Bougis PE; Martin-Eauclaire MF; Pongs O
Biochemistry; 2002 Dec; 41(51):15369-75. PubMed ID: 12484776
[TBL] [Abstract][Full Text] [Related]
33. Conformational exchange in the potassium channel blocker ShK.
Iwakawa N; Baxter NJ; Wai DCC; Fowler NJ; Morales RAV; Sugase K; Norton RS; Williamson MP
Sci Rep; 2019 Dec; 9(1):19307. PubMed ID: 31848433
[TBL] [Abstract][Full Text] [Related]
34. Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels.
Yin SJ; Jiang L; Yi H; Han S; Yang DW; Liu ML; Liu H; Cao ZJ; Wu YL; Li WX
J Proteome Res; 2008 Nov; 7(11):4890-7. PubMed ID: 18937510
[TBL] [Abstract][Full Text] [Related]
35. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
36. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
37. Disulfide bridge reorganization induced by proline mutations in maurotoxin.
Carlier E; Fajloun Z; Mansuelle P; Fathallah M; Mosbah A; Oughideni R; Sandoz G; Di Luccio E; Geib S; Regaya I; Brocard J; Rochat H; Darbon H; Devaux C; Sabatier JM; de Waard M
FEBS Lett; 2001 Feb; 489(2-3):202-7. PubMed ID: 11165250
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch.
Shijin Y; Hong Y; Yibao M; Zongyun C; Han S; Yingliang W; Zhijian C; Wenxin L
Peptides; 2008 Sep; 29(9):1514-20. PubMed ID: 18571286
[TBL] [Abstract][Full Text] [Related]
39. K
Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom.
Luna-Ramirez K; Csoti A; McArthur JR; Chin YKY; Anangi R; Najera RDC; Possani LD; King GF; Panyi G; Yu H; Adams DJ; Finol-Urdaneta RK
Biochem Pharmacol; 2020 Apr; 174():113782. PubMed ID: 31881193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
